help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Witko-Sarsat, V.
Right arrow Articles by Nadel, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Witko-Sarsat, V.
Right arrow Articles by Nadel, J. A.

Am. J. Respir. Cell Mol. Biol., Volume 20, Number 4, April, 1999 729-736

Proteinase 3, a Potent Secretagogue in Airways, Is Present in Cystic Fibrosis Sputum

Véronique Witko-Sarsat, Lise Halbwachs-Mecarelli, Antje Schuster, Patrick Nusbaum, Iris Ueki, Sandrine Canteloup, Gérard Lenoir, Béatrice Descamps-Latscha, and Jay A. Nadel

INSERM U 90, Hôpital des Enfants Malades, Paris, France; Children's Hospital, University of Düsseldorf, Germany; and Cardiovascular Research Institute and Department of Medicine and Physiology, University of California, San Francisco

We evaluated the roles of proteinase 3 (PR3) and human neutrophil elastase (HNE), two neutrophil serine proteinases in the mechanisms leading to airway inflammation and hypersecretion in cystic fibrosis (CF). Using specific enzyme-linked immunosorbent assay (ELISA), we found higher levels of PR3 than HNE in sputum from CF patients. Using two inhibitors, ICI (Imperial Chemical Industries) 200,355 (which inhibits both HNE and PR3) and secretory leukoproteinase inhibitor (SLPI) (which inhibits only HNE), we showed that PR3 was enzymatically active in sputum, and its activity, as assessed by SLPI-resistant serine proteinase activity, correlated highly with its antigenic concentration measured by ELISA. Interestingly, sputum pellet-associated serine proteinase activity was mostly due to HNE. PR3 purified from neutrophil azurophil granules triggered airway gland secretion, as measured by the release of radiolabeled molecules from cultured bovine tracheal serous cells pulse-labeled with Na235SO4. This secretory activity was inhibited by ICI 200,355. PR3 concentration in CF sputum was highly correlated with taurine concentration, a reliable marker of airway inflammation and respiratory scores (e.g., FEV1%), whereas no significant correlation was observed with HNE. We verified that Pseudomonas aeruginosa proteinases did not interfere with the assessment of PR3 and HNE. Indeed, the PR3/HNE ratio was greatest in patients chronically infected by P. aeruginosa. We suggest that PR3 may play a role in the hypersecretory process that is characteristic of CF.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
A. Guillabert, V. Wittamer, B. Bondue, V. Godot, V. Imbault, M. Parmentier, and D. Communi
Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation
J. Leukoc. Biol., December 1, 2008; 84(6): 1530 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P-R. Burgel and J. A. Nadel
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Eur. Respir. J., October 1, 2008; 32(4): 1068 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell
Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease
J. Leukoc. Biol., April 1, 2008; 83(4): 946 - 955.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Attucci, A. Gauthier, B. Korkmaz, P. Delepine, M. F.-D. Martino, F. Saudubray, P. Diot, and F. Gauthier
EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 803 - 809.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Dublet, A. Ruello, M. Pederzoli, E. Hajjar, M. Courbebaisse, S. Canteloup, N. Reuter, and V. Witko-Sarsat
Cleavage of p21/WAF1/CIP1 by Proteinase 3 Modulates Differentiation of a Monocytic Cell Line: MOLECULAR ANALYSIS OF THE CLEAVAGE SITE
J. Biol. Chem., August 26, 2005; 280(34): 30242 - 30253.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Pederzoli, C. Kantari, V. Gausson, S. Moriceau, and V. Witko-Sarsat
Proteinase-3 Induces Procaspase-3 Activation in the Absence of Apoptosis: Potential Role of this Compartmentalized Activation of Membrane-Associated Procaspase-3 in Neutrophils
J. Immunol., May 15, 2005; 174(10): 6381 - 6390.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. Korkmaz, S. Attucci, T. Moreau, E. Godat, L. Juliano, and F. Gauthier
Design and Use of Highly Specific Substrates of Neutrophil Elastase and Proteinase 3
Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 801 - 807.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
F Rubio, J Cooley, F J Accurso, and E Remold-O'Donnell
Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease
Thorax, April 1, 2004; 59(4): 318 - 323.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Durant, M. Pederzoli, Y. Lepelletier, S. Canteloup, P. Nusbaum, P. Lesavre, and V. Witko-Sarsat
Apoptosis-induced proteinase 3 membrane expression is independent from degranulation
J. Leukoc. Biol., January 1, 2004; 75(1): 87 - 98.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J., October 1, 2003; 22(4): 672 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Corvol, C. Fitting, K. Chadelat, J. Jacquot, O. Tabary, M. Boule, J.-M. Cavaillon, and A. Clement
Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L997 - L1003.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Witko-Sarsat, S. Canteloup, S. Durant, C. Desdouets, R. Chabernaud, P. Lemarchand, and B. Descamps-Latscha
Cleavage of p21waf1 by Proteinase-3, a Myeloid-specific Serine Protease, Potentiates Cell Proliferation
J. Biol. Chem., November 27, 2002; 277(49): 47338 - 47347.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Korkmaz, S. Attucci, E. Hazouard, M. Ferrandiere, M. L. Jourdan, M. Brillard-Bourdet, L. Juliano, and F. Gauthier
Discriminating between the Activities of Human Neutrophil Elastase and Proteinase 3 Using Serpin-derived Fluorogenic Substrates
J. Biol. Chem., October 11, 2002; 277(42): 39074 - 39081.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. E. Sorensen, P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
Blood, June 15, 2001; 97(12): 3951 - 3959.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. M. van der Geld, P. C. Limburg, and C. G. M. Kallenberg
Proteinase 3, Wegener's autoantigen: from gene to antigen
J. Leukoc. Biol., February 1, 2001; 69(2): 177 - 190.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Q.-L. Ying and S. R. Simon
Kinetics of the Inhibition of Proteinase 3 by Elafin
Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 83 - 89.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A. Hill, S. Gompertz, and R. Stockley
Factors influencing airway inflammation in chronic obstructive pulmonary disease
Thorax, November 1, 2000; 55(11): 970 - 977.
[Full Text]

Home page
 J. Immunol.Home page
E. J. Campbell, M. A. Campbell, and C. A. Owen
Bioactive Proteinase 3 on the Cell Surface of Human Neutrophils: Quantification, Catalytic Activity, and Susceptibility to Inhibition
J. Immunol., September 15, 2000; 165(6): 3366 - 3374.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]

Home page
 BloodHome page
V. Witko-Sarsat, E. M. Cramer, C. Hieblot, J. Guichard, P. Nusbaum, S. Lopez, P. Lesavre, and L. Halbwachs-Mecarelli
Presence of Proteinase 3 in Secretory Vesicles: Evidence of a Novel, Highly Mobilizable Intracellular Pool Distinct From Azurophil Granules
Blood, October 1, 1999; 94(7): 2487 - 2496.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1999 American Thoracic Society. 		  Red In Translatin